Preliminary Observations Suggesting That Treatment With Modafinil Improves Fatigue in Patients With Orthostatic Intolerance
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Many patients who suffer from orthostatic intolerance (OI) may also have severe fatigue and extreme exercise intolerance. In some of these patients, fatigue may be so severe that they are unable to maintain employment. In some, even the activities of the daily living may be compromised. We report on the use of modafinil in a subgroup of patients who failed therapy with commonly used medication for fatigue in patients with OI. The study was approved by the institutional review board. A retrospective nonrandomized analysis was preformed on 60 patients evaluated at our autonomic center for OI from 2003 to 2010. The diagnosis of OI was based on patient history, physical examination, and reponse to head up tilt table testing. All these patients had fatigue as their predominant symptom. Multiple trials of stimulants including methylphenidate, amphetamine, or dextroamphetamine failed to provide symptomatic relief of fatigue in these patients. Each patient received modafinil (100-200 mg daily). The mean follow-up period was 9 ± 3 months. A treatment was considered successful if it provided symptomatic relief from fatigue for the patient. Sixty patients, age 29 ± 15, 52 women were included in the analysis. Migraine (57%) and joint hypermobility syndrome (33%) were common comorbidities. Out of 60 patients, 40 patients reported initial improvement with initiation of modafinil therapy. Twenty patients reported no change in their symptoms of fatigue. Of the 40 patients who showed initial improvement in their symptoms 4 had eventual recurrence of fatigue after 3 months of modafinil therapy. Thirty-six patients continued to demonstrate symptom relief from fatigue for more than 6 months. In a selective group of patients of OI, modafinil may improve fatigue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713 · cited 1×
“The pharmacologic effects of modafinil are complex and it is thought to alter various neurotransmitters in the brain.(17) In animal studies, modafinil has been reported to decrease the levels of inhibitory neurotransmitters gamma amino butyric acid and increase the levels of glutamate and serotonin.”
BackgroundFreudenreich, O., Henderson, D. C., Macklin, E. A., Evins, A. E., Fan, X., Cather, C., Walsh, J. P., & Goff, D. C. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04683 · Cited by 78
Cited by
Castori, M. (2012) · ISRN Dermatology · doi:10.5402/2012/751768 · Cited by 222
Efficacy of Therapies for Postural Tachycardia Syndrome: A Systematic Review and Meta-analysis
Wells, R., Elliott, A. D., Mahajan, R., Page, A., Iodice, V., Sanders, P., & Lau, D. H. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.01.025 · Cited by 67
Kpaeyeh, J., Mar, P. L., Raj, V., Black, B. K., Arnold, A. C., Biaggioni, I., Shibao, C. A., Paranjape, S. Y., Dupont, W. D., Robertson, D., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000221 · Cited by 29
“There were no significant differences between the symptom scores of the modafinil and placebo groups at baseline (15 [10] vs 18 [16]; P = 0.”
BackgroundKICHLOO, A., ALJADAH, M., GRUBB, B., & KANJWAL, K. (2021) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2021.120705 · Cited by 15
Self-citation
Metadata
- Authors
- Kanjwal, K., Saeed, B., Karabin, B., Kanjwal, Y., & Grubb, B. P.
- Venue
- American Journal of Therapeutics
- Published
- 2011-11
- Volume
- 18
- Issue
- 6
- Pages
- 449-452
- ISSN
- 1075-2765 (ISSN-L)
- OpenAlex
- W2055087108
- Cited by
- 12
- References
- 2
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preliminary Observations Suggesting That Treatment With Modafinil Improves Fatigue in Patients With Orthostatic Intolerance. https://app.cochat.ai/papers/10.1097/mjt.0b013e3181da0763
- The paper
- Kanjwal, K., Saeed, B., Karabin, B., Kanjwal, Y., & Grubb, B. P. (2011). Preliminary Observations Suggesting That Treatment With Modafinil Improves Fatigue in Patients With Orthostatic Intolerance. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0b013e3181da0763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.